Purinergic receptors are part of a signaling system for keratinocyte proliferation, differentiation, and apoptosis in human fetal epidermis

被引:63
作者
Greig, AVH
Linge, C
Cambrey, A
Burnstock, G
机构
[1] UCL Royal Free & Univ Coll Med Sch, Autonom Neurosci Inst, London NW3 2PF, England
[2] Mt Vernon Hosp, RAFT Inst Plast Surg, Northwood HA6 2RN, Middx, England
基金
英国惠康基金;
关键词
apoptosis; cell differentiation; proliferation receptors; periderm; purinergic P2;
D O I
10.1046/j.1523-1747.2003.12567.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We have investigated the expression of P2X(5), P2X(7), P2Y(1), and P2Y(2) receptor subtypes in 8- to 11-wk-old human fetal epidermis in relation to markers of pro-liferation (proliferating cell nuclear antigen (PCNA) and Ki-67), keratinocyte differentiation (cytokeratin K10 and involucrin), and markers of apoptosis (TdT-mediated dUTP nick end labeling (TUNEL) and anti-caspase-3). Immunohistochemistry showed that each of the four receptors was expressed in spatially distinct zones of the developing epidermis: P2Y(1) receptors were found in the basal layer, P2X(5) receptors were predominantly in the basal and intermediate layers, and both P2Y(2) and P2X(7) receptors were in the periderm. Colo-calization experiments suggested different functional roles for these receptors. P2Y(1) receptors were found in fetal keratinocytes positive for PCNA and Ki-67, suggesting a role in proliferation. P2X(5) receptors double labeled with differentiated fetal keratinocytes that were positive for cytokeratin K10, suggesting a role in differentiation. P2X(7) receptors colocalized with anti-caspase-3 antibody and were also expressed in periderm cells positive for TUNEL, suggesting a role in periderm cell apoptosis. P2Y(2) receptors were found only in periderm cells and may have a role in chloride and fluid secretion into the amniotic fluid.
引用
收藏
页码:1145 / 1149
页数:5
相关论文
共 36 条
  • [1] PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS
    ABBRACCHIO, MP
    BURNSTOCK, G
    [J]. PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) : 445 - 475
  • [2] Purinergic signalling: Pathophysiological roles
    Abbracchio, MP
    Burnstock, G
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1998, 78 (02) : 113 - 145
  • [3] Periderm cells form cornified cell envelope in their regression process during human epidermal development
    Akiyama, M
    Smith, LT
    Yoneda, K
    Holbrook, KA
    Hohl, D
    Shimizu, H
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (06) : 903 - 909
  • [4] LABEL-RETAINING CELLS IN HUMAN-EMBRYONIC AND FETAL EPIDERMIS
    BICKENBACH, JR
    HOLBROOK, KA
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 88 (01) : 42 - 46
  • [5] Purinergic signalling: ATP release
    Bodin, P
    Burnstock, G
    [J]. NEUROCHEMICAL RESEARCH, 2001, 26 (8-9) : 959 - 969
  • [6] Introduction: ATP and its metabolites as potent extracellular agents
    Burnstock, G
    [J]. EXTRACELLULAR NUCLEOTIDES AND NUCLEOSIDES: RELEASE, RECEPTORS, AND PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL EFFECTS, 2003, 54 : 1 - 27
  • [7] Burnstock G, 2001, HANDB EXP PHARM, V151, P89
  • [8] Burnstock G., 1978, CELL MEMBRAIN RECEPT, P107, DOI DOI 10.1016/0014-5793(79)81367-8
  • [9] EXPRESSION OF EPIDERMAL KERATINS AND FILAGGRIN DURING HUMAN-FETAL SKIN DEVELOPMENT
    DALE, BA
    HOLBROOK, KA
    KIMBALL, JR
    HOFF, M
    SUN, TT
    [J]. JOURNAL OF CELL BIOLOGY, 1985, 101 (04) : 1257 - 1269
  • [10] Regulation of epidermal homeostasis through P2Y2 receptors
    Dixon, CJ
    Bowler, WB
    Littlewood-Evans, A
    Dillon, JP
    Bilbe, G
    Sharpe, GR
    Gallagher, JA
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (07) : 1680 - 1686